Amanote Research
Register
Sign In
High-Dose Atorvastatin vs Usual-Dose Simvastatin for Secondary Prevention After Myocardial Infarction: The IDEAL Study: A Randomized Controlled Trial—Correction
JAMA - Journal of the American Medical Association
- United States
doi 10.1001/jama.294.24.3092
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Date
December 28, 2005
Authors
Unknown
Publisher
American Medical Association (AMA)
Related search
The Impact of Dose of the Angiotensin-Receptor Blocker Valsartan on the Post-Myocardial Infarction Ventricular Remodeling: Study Protocol for a Randomized Controlled Trial
Trials
Medicine
Pharmacology
Dose Optimisation Following Myocardial Infarction
Prescriber
Pharmacology
(Summary of the Recommendations for Long-Term Secondary Prevention After Myocardial Infarction)
Cor et Vasa
Cardiovascular Medicine
Cardiology
Early Stenting vs Conservative Treatment After Thrombolysis in Acute Myocardial Infarction: Results of a Randomized Trial
Critical Care
Critical Care
Intensive Care Medicine
Efficacy of Short-Term High-Dose Atorvastatin for Prevention of Contrast-Induced Nephropathy in Patients With ST Segment Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention
Heart
Cardiovascular Medicine
Cardiology
PRevention of INCisional Hernia After Liver Transplantation (PRINC Trial): Study Protocol for a Randomized Controlled Trial
Trials
Medicine
Pharmacology
Randomized Controlled Trial of Prolonged Second Stage: Extending the Time Limit vs Usual Guidelines
American Journal of Obstetrics and Gynecology
Gynecology
Obstetrics
Acute Myocardial Infarction After Administration of Low-Dose Intravenous Epinephrine for Anaphylaxis
Canadian Journal of Emergency Medicine
Emergency Medicine
A Double-Blinded Randomised Placebo-Controlled Phase II Trial to Evaluate High Dose Rifampicin for Tuberculous Meningitis: A Dose Finding Study
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
